CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$63,899,000
+92.0%
1,379,207
+1.1%
0.04%
+85.7%
Q1 2019$33,275,000
+92.4%
1,364,811
+12.4%
0.02%
+61.5%
Q4 2018$17,298,000
-8.6%
1,213,843
-2.6%
0.01%0.0%
Q3 2018$18,935,000
-2.6%
1,245,672
+7.5%
0.01%
-7.1%
Q2 2018$19,436,000
+12.9%
1,158,280
+9.8%
0.01%
+7.7%
Q1 2018$17,216,000
+39.8%
1,054,850
+9.7%
0.01%
+30.0%
Q4 2017$12,313,000
+27.0%
961,894
+22.1%
0.01%
+25.0%
Q3 2017$9,693,000
+58.4%
788,002
+7.8%
0.01%
+33.3%
Q2 2017$6,121,000
-5.6%
731,187
+0.9%
0.01%0.0%
Q1 2017$6,481,000
+9.5%
724,869
+7.7%
0.01%0.0%
Q4 2016$5,919,000
+76.2%
673,293
+35.3%
0.01%
+50.0%
Q3 2016$3,359,000
+83.1%
497,611
-3.4%
0.00%
+100.0%
Q2 2016$1,835,000
+22.7%
515,317
+1.7%
0.00%0.0%
Q1 2016$1,496,000
-28.7%
506,869
+1.9%
0.00%
-33.3%
Q4 2015$2,099,000
-9.7%
497,245
-2.4%
0.00%0.0%
Q3 2015$2,324,000
-29.5%
509,437
+11.4%
0.00%
-40.0%
Q2 2015$3,296,000
+0.5%
457,131
+2.7%
0.01%0.0%
Q1 2015$3,281,000
+100.3%
445,050
+28.6%
0.01%
+150.0%
Q4 2014$1,638,000
+35.5%
346,197
+2.2%
0.00%0.0%
Q3 2014$1,209,000
-23.6%
338,633
-2.4%
0.00%
-33.3%
Q2 2014$1,583,000
+8.3%
347,119
+11.7%
0.00%0.0%
Q1 2014$1,462,000
+4.1%
310,859
+10.9%
0.00%0.0%
Q4 2013$1,404,000
-19.7%
280,234
+3.3%
0.00%
-25.0%
Q3 2013$1,748,000
+35.6%
271,372
-0.4%
0.00%
+33.3%
Q2 2013$1,289,000272,4500.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2013
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders